BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36385557)

  • 1. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
    Christine A; Park MK; Song SJ; Song MS
    Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
    He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
    J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.
    Deng R; Guo Y; Li L; He J; Qiang Z; Zhang H; Chen R; Wang Y; Zhao X; Yu J
    Mol Oncol; 2021 Jan; 15(1):279-298. PubMed ID: 33155366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissenting degradation: Deubiquitinases in cell cycle and cancer.
    Bonacci T; Emanuele MJ
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity.
    Han Y; Yun CC
    FASEB J; 2020 Dec; 34(12):16476-16488. PubMed ID: 33095475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
    Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
    Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression.
    Park MK; Yao Y; Xia W; Setijono SR; Kim JH; Vila IK; Chiu HH; Wu Y; Billalabeitia EG; Lee MG; Kalb RG; Hung MC; Pandolfi PP; Song SJ; Song MS
    Nat Commun; 2019 Feb; 10(1):636. PubMed ID: 30733438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer.
    Wang K; Liu J; Li YL; Li JP; Zhang R
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188723. PubMed ID: 35314212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HECT family of E3 ubiquitin ligases and PTEN.
    Song MS; Pandolfi PP
    Semin Cancer Biol; 2022 Oct; 85():43-51. PubMed ID: 34129913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia.
    Noguera NI; Song MS; Divona M; Catalano G; Calvo KL; GarcĂ­a F; Ottone T; Florenzano F; Faraoni I; Battistini L; Colombo E; Amadori S; Pandolfi PP; Lo-Coco F
    Leukemia; 2013 Apr; 27(5):1037-43. PubMed ID: 23183427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes.
    Doherty LM; Mills CE; Boswell SA; Liu X; Hoyt CT; Gyori B; Buhrlage SJ; Sorger PK
    Elife; 2022 Jun; 11():. PubMed ID: 35737447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
    Panner A; Crane CA; Weng C; Feletti A; Fang S; Parsa AT; Pieper RO
    Cancer Res; 2010 Jun; 70(12):5046-53. PubMed ID: 20484045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.
    Satija YK; Bhardwaj A; Das S
    Int J Cancer; 2013 Dec; 133(12):2759-68. PubMed ID: 23436247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc.
    Kwak YD; Wang B; Pan W; Xu H; Jiang X; Liao FF
    J Biol Chem; 2010 Mar; 285(13):9847-9857. PubMed ID: 20100827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359.
    Rodriguez J; Herrero A; Li S; Rauch N; Quintanilla A; Wynne K; Krstic A; Acosta JC; Taylor C; Schlisio S; von Kriegsheim A
    Cell Rep; 2018 Jul; 24(5):1316-1329. PubMed ID: 30067985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity.
    Errafiy R; Aguado C; Ghislat G; Esteve JM; Gil A; Loutfi M; Knecht E
    PLoS One; 2013; 8(12):e83318. PubMed ID: 24349488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN.
    Sun J; Li T; Zhao Y; Huang L; Sun H; Wu H; Jiang X
    Mol Cell Biochem; 2018 Apr; 441(1-2):1-7. PubMed ID: 28852924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP.
    Morotti A; Panuzzo C; Crivellaro S; Pergolizzi B; Familiari U; Berger AH; Saglio G; Pandolfi PP
    Leukemia; 2014 Jun; 28(6):1326-33. PubMed ID: 24317448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
    Yuan L; Lv Y; Li H; Gao H; Song S; Zhang Y; Xing G; Kong X; Wang L; Li Y; Zhou T; Gao D; Xiao ZX; Yin Y; Wei W; He F; Zhang L
    Nat Cell Biol; 2015 Sep; 17(9):1169-81. PubMed ID: 26280536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease.
    Rawat R; Starczynowski DT; Ntziachristos P
    Curr Opin Cell Biol; 2019 Jun; 58():85-94. PubMed ID: 30897496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.